(Q34023588)

English

Safety and immunogenicity of an HIV adenoviral vector boost after DNA plasmid vaccine prime by route of administration: a randomized clinical trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Safety and immunogenicity of an HIV adenoviral vector boost after DNA plasmid vaccine prime by route of administration: a randomized clinical trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

11

object named as

M Juliana McElrath

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

David C. Montefiori

10

object named as

David C Montefiori

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Barney S. Graham

14

object named as

Barney S Graham

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Lindsey R Baden

7

object named as

Lindsey Baden

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

1

object named as

Beryl A Koblin

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Georgia D. Tomaras

9

object named as

Georgia D Tomaras

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

author name string

Martin Casapia

2

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Cecilia Morgan

3

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Li Qin

4

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Zhixue Maggie Wang

5

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Olivier D Defawe

6

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Paul Goepfert

8

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Lilian Saavedra

12

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Chuen-Yen Lau

13

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

NIAID HIV Vaccine Trials Network

15

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

language of work or name

0 references

publication date

12 September 2011

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

e24517

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

copyright license

Creative Commons Attribution 4.0 International

12 September 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Safety and immunogenicity of a replication-defective adenovirus type 5 HIV vaccine in Ad5-seronegative persons: a randomized clinical trial (HVTN 054)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171485

28 July 2018

Safety and immunogenicity study of Multiclade HIV-1 adenoviral vector vaccine alone or as boost following a multiclade HIV-1 DNA vaccine in Africa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171485

28 July 2018

Safety and immunogenicity of modified vaccinia Ankara (ACAM3000): effect of dose and route of administration.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171485

28 July 2018

Priming immunization with DNA augments immunogenicity of recombinant adenoviral vectors for both HIV-1 specific antibody and T-cell responses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171485

28 July 2018

Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171485

28 July 2018

Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171485

28 July 2018

Challenges in the development of an HIV-1 vaccine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171485

28 July 2018

Multifunctional T-cell characteristics induced by a polyvalent DNA prime/protein boost human immunodeficiency virus type 1 vaccine regimen given to healthy adults are dependent on the route and dose of administration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171485

28 July 2018

Cellular immune responses induced with dose-sparing intradermal administration of HIV vaccine to HIV-uninfected volunteers in the ANRS VAC16 trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171485

28 July 2018

Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 DNA candidate vaccine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171485

28 July 2018

Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 candidate vaccine delivered by a replication-defective recombinant adenovirus vector

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171485

28 July 2018

Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171485

28 July 2018

Immunization with DNA through the skin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171485

28 July 2018

Visualizing priming of virus-specific CD8+ T cells by infected dendritic cells in vivo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171485

28 July 2018

Epidermal Langerhans cells: from neurons to nature's adjuvants

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3171485

28 July 2018

Intradermal influenza vaccine for older adults: a randomized controlled multicenter phase III study.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0024517

21 January 2018

Anthrax vaccine: immunogenicity and safety of a dose-reduction, route-change comparison study in humans

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0024517

21 January 2018

Comparison of higher-dose intradermal hepatitis B vaccination to standard intramuscular vaccination of healthcare workers

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0024517

21 January 2018

Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunity

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0024517

21 January 2018

Durable HIV-1 antibody and T-cell responses elicited by an adjuvanted multi-protein recombinant vaccine in uninfected human volunteers

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0024517

21 January 2018

Peptide selection for human immunodeficiency virus type 1 CTL-based vaccine evaluation

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0024517

21 January 2018

Statistical positivity criteria for the analysis of ELISpot assay data in HIV-1 vaccine trials

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0024517

21 January 2018

Optimization and validation of an 8-color intracellular cytokine staining (ICS) assay to quantify antigen-specific T cells induced by vaccination

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0024517

21 January 2018

Development of an automated analysis system for data from flow cytometric intracellular cytokine staining assays from clinical vaccine trials

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0024517

21 January 2018

A phase 1/2 study of a multiclade HIV-1 DNA plasmid prime and recombinant adenovirus serotype 5 boost vaccine in HIV-Uninfected East Africans (RV 172).

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0024517

21 January 2018

Choosing a route of administration for quadrivalent meningococcal polysaccharide vaccine: intramuscular versus subcutaneous

1 reference

https://pubmed.ncbi.nlm.nih.gov/21931737

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High seroprotection rate induced by intradermal administration of a recombinant hepatitis B vaccine in young healthy adults: comparison with standard intramuscular vaccination

1 reference

https://pubmed.ncbi.nlm.nih.gov/21931737

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum antibody responses after intradermal vaccination against influenza

1 reference

https://pubmed.ncbi.nlm.nih.gov/21931737

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dose sparing with intradermal injection of influenza vaccine

1 reference

https://pubmed.ncbi.nlm.nih.gov/21931737

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of HIV vaccine-induced cell-mediated immunity in HIV-seronegative clinical trial participants using an optimized and validated enzyme-linked immunospot assay

1 reference

https://pubmed.ncbi.nlm.nih.gov/21931737

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I clinical evaluation of a six-plasmid multiclade HIV-1 DNA candidate vaccine

1 reference

https://pubmed.ncbi.nlm.nih.gov/21931737

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Virosomal hepatitis a vaccine: comparing intradermal and subcutaneous with intramuscular administration

1 reference

https://pubmed.ncbi.nlm.nih.gov/21931737

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0024517

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

2011PLoSO...624517K

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34023588&oldid=1868850411"